The BIOTEK2021 programme is the Research Council of Norway’s most comprehensive research initiative in the field of biotechnology. This week, ten projects were granted a combined NOK 76 million, out of a total of 26 projects applying for NOK 194 million. This implies that almost 40% of the applications were granted, which should encourage a number of researchers at our department to take part in this competition! One of the ten excellent and grant-winning proposals, and the only one from UiB, is the project Novel drug candidates for Chronic Obstructive Pulmonary Disease treatment, led by professor Nathalie Reuter at the department of molecular biology. She put together a strong team that includes our own Bengt Erik Haug in a major role.
Three observations come easily. Firstly, it is gratifying to note the competitiveness of a research collaboration involving the two departments at UiB that focus on molecular science! Secondly, in light of our strengthened ties to BTO, it may be of interest to note that this project is granted in an optimization call, where BTO plays an important part. You should know where and when to look up BTO-Elisabeth! Finally, it is in place to note that this is Bengt Erik’s second home run this fall. Hardly a coincidence – Congratulations!!